ArticleCommunications medicine2025
Durability of next-generation self-replicating RNA vaccine RBI-4000: a phase 1, randomized open label clinical trial.
Christian J Maine et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it